Cross Country Healthcare, Inc.
CCRN
$14.13
-$0.13-0.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -25.14% | -28.75% | -37.16% | -39.11% | -34.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.14% | -28.75% | -37.16% | -39.11% | -34.09% |
| Cost of Revenue | -23.37% | -27.24% | -35.59% | -37.54% | -33.87% |
| Gross Profit | -31.49% | -34.10% | -42.50% | -44.56% | -34.87% |
| SG&A Expenses | -22.78% | -22.47% | -3.60% | -27.62% | -14.99% |
| Depreciation & Amortization | -2.91% | -0.93% | 6.48% | -5.34% | 41.40% |
| Other Operating Expenses | 7,772.00% | -- | -- | -- | -- |
| Total Operating Expenses | -22.54% | -26.14% | -30.01% | -35.73% | -30.70% |
| Operating Income | -97.62% | -81.52% | -135.57% | -82.11% | -72.17% |
| Income Before Tax | -130.18% | -82.62% | -164.55% | -90.80% | -72.02% |
| Income Tax Expenses | -104.10% | -87.53% | -139.19% | -90.67% | -48.00% |
| Earnings from Continuing Operations | -141.52% | -80.06% | -175.19% | -90.85% | -76.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -141.52% | -80.06% | -175.19% | -90.85% | -76.70% |
| EBIT | -97.62% | -81.52% | -135.57% | -82.11% | -72.17% |
| EBITDA | -78.23% | -67.10% | -120.24% | -74.62% | -66.14% |
| EPS Basic | -144.30% | -78.88% | -178.27% | -90.41% | -75.37% |
| Normalized Basic EPS | -101.07% | -76.83% | -141.64% | -77.66% | -69.57% |
| EPS Diluted | -145.94% | -78.50% | -178.77% | -90.28% | -74.93% |
| Normalized Diluted EPS | -101.08% | -76.73% | -141.83% | -77.48% | -69.35% |
| Average Basic Shares Outstanding | -6.22% | -5.54% | -3.93% | -4.60% | -5.41% |
| Average Diluted Shares Outstanding | -6.77% | -5.96% | -4.40% | -5.37% | -6.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |